Vaccinex annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
Vaccinex's operating margin was −3,117.30% for fiscal 2024.
View full Vaccinex company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −3,117.30% | +897.61 pp |
| 2023 | 2023-12-31 | −4,014.91% | +3223.63 pp |
| 2022 | 2022-12-31 | −7,238.55% | −4739.66 pp |
| 2021 | 2021-12-31 | −2,498.89% | +2034.07 pp |
| 2020 | 2020-12-31 | −4,532.96% | +1588.45 pp |
| 2019 | 2019-12-31 | −6,121.41% | −2353.32 pp |
| 2018 | 2018-12-31 | −3,768.09% | +19680.79 pp |
| 2017 | 2017-12-31 | −23,448.89% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −1,590.14% | +27579.86 pp |
| Q3 2024 | 2024-09-30 | −8,753.85% | −7847.30 pp |
| Q2 2024 | 2024-06-30 | −2,466.38% | +7117.62 pp |
| Q1 2024 | 2024-03-31 | −4,878.85% | +5247.15 pp |
| Q3 2023 | 2023-09-30 | −29,170.00% | −28435.88 pp |
| Q1 2023 | 2023-03-31 | −906.55% | +466.73 pp |
| Q3 2022 | 2022-09-30 | −9,584.00% | −7683.50 pp |
| Q3 2021 | 2021-09-30 | −10,126.00% | +25306.00 pp |
| Q1 2021 | 2021-03-31 | −734.12% | +8989.29 pp |
| Q3 2020 | 2020-09-30 | −1,373.28% | +3039.61 pp |
| Q3 2019 | 2019-09-30 | −1,900.50% | +1359.10 pp |
| Q2 2019 | 2019-06-30 | −35,432.00% | −30228.03 pp |
| Q1 2019 | 2019-03-31 | −9,723.40% | −6952.05 pp |
| Q4 2018 | 2018-12-31 | −4,412.89% | — |
| Q3 2018 | 2018-09-30 | −3,259.60% | — |
| Q2 2018 | 2018-06-30 | −5,203.97% | — |
| Q1 2018 | 2018-03-31 | −2,771.36% | — |
Over the last five reported fiscal years, Vaccinex's operating margin increased from −6,121.41% to −3,117.30%, a change of +3004.11 percentage points. The latest reported quarter, Q4 2024, shows −1,590.14%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex filings at SEC.gov ↗